Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Int J Gynaecol Obstet. 2014 May 13;126(3):213–216. doi: 10.1016/j.ijgo.2014.03.026

Table 1.

Incidence of conditions in which the use of contraceptive methods is restricted (Category 3 or 4) according to WHO [4].a

Condition Contraindicated method Frequency in the present study (n = 281)
Breastfeeding (≥ 6 weeks and < 6 months postpartum) CHC 20 (7.1)
Ritonavir use CHC, POP 6 (2.1)
Pregnancy All 5 (1.8)
Hypertension b CHC 2 (0.7)
Migraine without aura, >35 years of age CHC 2 (0.7)
Cervical mass IUD 2 (0.7)
Rifampicin use CHC 1 (0.4)
Stroke CHC, DMPA 1 (0.4)
Active cervicitis IUD 1 (0.4)

Abbreviations: CHC, combined hormonal contraceptive; DMPA, depot medroxyprogesterone acetate; IUD, intrauterine device; POP, progestogen-only contraceptive pill.

a

Values are given as number (percentage).

b

Systolic blood pressure 140–159 mm Hg, diastolic blood pressure 90–99 mm Hg, or history of hypertension if blood pressure could not be evaluated.